Low-Plastic Diet Lowers Urinary Phthalates and Bisphenols: Evidence from the PERTH Randomized Trial

What Did the PERTH Trial Actually Test?

The PERTH (Plastic Exposure Reduction Trial) investigators enrolled healthy adults and allocated them either to a structured low-plastic dietary intervention or to continue their usual diet. Participants in the intervention arm were coached to avoid foods and beverages packaged in common plastic materials, reduce use of plastic-lined cans and takeaway containers, and prefer glass, stainless steel, or paper-based alternatives where feasible. Urine samples were collected at baseline and after the intervention period to measure metabolites of di(2-ethylhexyl) phthalate (DEHP), other high-molecular-weight phthalates, and bisphenols such as BPA, BPS, and BPF.

The trial is significant because most evidence linking plasticizer exposure to health risks has come from cross-sectional or cohort data. By randomizing the behavioral intervention, PERTH can test whether a realistic dietary change actually lowers internal dose — the first step in demonstrating that policy or individual changes can reduce exposure in real-world settings. The researchers reported meaningful reductions in several urinary metabolites in the low-plastic arm compared with controls, with effects visible within weeks of behavior change.

Why Do Phthalates and Bisphenols Matter for Health?

Phthalates are plasticizers used to soften PVC and are found in food packaging, medical devices, and personal care products. Bisphenols, including BPA and its structural analogs, are used in polycarbonate plastics and the epoxy linings of food cans. Both classes are detected in the urine of most people tested in national biomonitoring surveys such as the U.S. CDC's NHANES program. Their rapid metabolism means that urinary measurements reflect recent exposure, largely dietary in origin for the general population.

Observational data from NHANES and European cohorts have associated higher phthalate metabolite levels with cardiovascular mortality, insulin resistance, and adverse reproductive outcomes, while BPA exposure has been linked to metabolic and developmental endpoints. Regulatory bodies including the European Food Safety Authority have tightened tolerable daily intake values for BPA in recent years. A trial that demonstrates exposure can be lowered through diet strengthens the rationale for both individual risk reduction and broader food-contact material reform.

What Are the Clinical and Policy Implications?

For clinicians, PERTH offers an evidence base to counsel patients — particularly those who are pregnant, planning pregnancy, or managing cardiometabolic risk — that simple changes in food storage, preparation, and packaging may measurably reduce endocrine disruptor exposure. Suggestions grounded in the trial's intervention include preferring fresh or minimally packaged foods, avoiding heating food in plastic containers, and reducing consumption of canned foods with epoxy linings when alternatives exist.

For policy, the trial adds weight to calls for stricter regulation of food-contact materials. The U.S. FDA, European Commission, and national health agencies have been under increasing pressure to reassess phthalate and bisphenol use in food packaging. Demonstrating that behavior change alone produces measurable biological reductions implies that upstream regulatory action — removing these chemicals from the food supply — could have population-scale effects on internal exposure.